Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
We describe two cystic fibrosis patients infected with pandrug-resistant Burkholderia cepacia complex, with the exception of ceftazidime-avibactam, who received prophylaxis with this antibiotic during lung transplantation. Although both patients had a post-operative relapse of respiratory infection, one with positive blood cultures, ceftazidime-avibactam treatment yielded a favourable outcome. 12 months after transplantation, one patient presented an excellent clinical outcome. However, the other patient died 10 months later due to severe B. cepacia sinusitis with intracranial invasion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patients may be candidates at specialized centers that have attained satisfactory outcomes with protocols implementing newer antibiotic combinations and intense management of sinusitis.(74–77)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [75]
Citations
Cites
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
van Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis
Murray, S., Charbeneau, J., Marshall, B. C., & LiPuma, J. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1834oc · Cited by 177
Alexander, B. D., Petzold, E. W., Reller, L. B., Palmer, S. M., Davis, R. D., Woods, C. W., & LiPuma, J. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02186.x · Cited by 177
De Soyza, A., Meachery, G., Hester, K. L. M., Nicholson, A., Parry, G., Tocewicz, K., Pillay, T., Clark, S., Lordan, J. L., Schueler, S., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.06.007 · Cited by 168
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
New β-Lactam–β-Lactamase Inhibitor Combinations
Yahav, D., Giske, C. G., Grāmatniece, A., Abodakpi, H., Tam, V. H., & Leibovici, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-20 · Cited by 521
Soriano, À., Carmeli, Y., Omrani, A. S., Moore, L. S. P., Tawadrous, M., & Irani, P. M. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00507-6 · Cited by 113
Strich, J. R., Ricotta, E., Warner, S., Lai, Y. L., Demirkale, C. Y., Hohmann, S. F., Rhee, C., Klompas, M., Palmore, T. N., Powers, J. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa061 · Cited by 36
Nuevos antibióticos para el tratamiento de las infecciones por microorganismos multirresistentes
Escolà‐Vergé, L., Arcos, I. L., & Almirante, B. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2019.11.002 · Cited by 34
Metadata
- Authors
- Los-Arcos, I., Len, O., Martín-Gómez, M. T., González-López, J. J., Saéz-Giménez, B., Deu, M., Nuvials, X., Ferrer, R., Román, A., & Gavaldà, J.
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Universitat Autònoma de Barcelona (ES)
- Venue
- Infection
- Published
- 2018-12-19
- Volume
- 47
- Issue
- 2
- Pages
- 289-292
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W2904064684
- Cited by
- 24
- References
- 20
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Burkholderia infections and melioidosis
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- lung transplantation, cystic fibrosis, Burkholderia cepacia complex, pan-drug resistance, ceftazidime-avibactam, antibiotic prophylaxis, sinusitis, intracranial invasion, blood culture
- MeSH terms
- Adult, Anti-Bacterial Agents, Ceftazidime, Cystic Fibrosis, Drug Combinations, Humans, Male, Lung Transplantation, Treatment Outcome, Drug Resistance, Multiple, Bacterial, Burkholderia cepacia complex, Azabicyclo Compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam. https://app.cochat.ai/papers/10.1007/s15010-018-1261-y
- The paper
- Los-Arcos, I., Len, O., Martín-Gómez, M. T., González-López, J. J., Saéz-Giménez, B., Deu, M., Nuvials, X., Ferrer, R., Román, A., & Gavaldà, J. (2019). Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam. Infection. https://doi.org/10.1007/s15010-018-1261-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.